-
Kenya's economy faces climate change risks: World Bank
-
Hantavirus: spread by rodents, potentially fatal, with no specific cure
-
Musk vs OpenAI trial enters second week
-
Japan PM says oil crisis has 'enormous impact' in Asia-Pacific
-
Seoul, Taipei hit records as Asian stocks track Wall St tech rally
-
Boeing faces civil trial over 737 MAX crash
-
Pacific Avenue Capital Partners Enters into Exclusive Negotiations to Acquire ESE World, Amcor's European Waste Container Business
-
Three die on Atlantic cruise ship from suspected hantavirus: WHO
-
Two die in 'respiratory illness' outbreak on Atlantic cruise ship
-
More Nepalis drive electric, evading global fuel shocks
-
Latecomer Japan eyes slice of rising global defence spending
-
German fertiliser makers and farmers struggle with Iran war fallout
-
OPEC+ to make first post-UAE production decision
-
Massive crowds fill Rio's Copacabana beach for Shakira concert
-
US airlines step up as Spirit winds down
-
Aviation companies step up as Spirit winds down
-
'Bookless bookstore': audio-only book shop opens in New York
-
Venezuelan protesters call government wage hike a joke
-
S&P 500, Nasdaq end at fresh records on tech earnings strength
-
Pope names former undocumented migrant as US bishop of West Virginia
-
Trump says will raise US tariffs on EU cars to 25%
-
ExxonMobil CEO sees chance of higher oil prices as earnings dip
-
After Madonna and Lady Gaga, Shakira set for Rio beach mega-gig
-
King Charles gets warm welcome in Bermuda after whirlwind US visit
-
Coe hails IOC gender testing decision
-
Baguettes take centre stage on France's Labour Day
-
Iran offers new proposal amid stalled US peace talks
-
French hub monitors Hormuz tensions from afar
-
Oil steady after wild swing, stocks diverge in thin trading
-
Chinese swimmer Sun Yang reports cyberbullying to police
-
Iran activates air defences as Trump faces congressional deadline
-
India's cows offer biogas alternative to Mideast energy crunch
-
Crude edges up after wild swing, stocks track Wall St rally
-
Formerra Appoints Matt Borowiec as Chief Commercial Officer
-
New Princess Diana documentary promises her own words
-
Oil slumps after hitting peak, US indices reach new records
-
Venezuela leader hikes minimum wage package by 26%
-
Apple earnings beat forecasts on iPhone 17 demand
-
Bangladesh signs biggest-ever plane deal for 14 Boeings
-
Musk grilled on AI profits at OpenAI trial
-
Venezuela opens arms to world with Miami-Caracas flight
-
US Congress votes to end record government shutdown
-
First direct US-Venezuela flight in years arrives in Caracas
-
Just telling nations to quit fossil fuels 'not realistic': COP31 chief
-
Trump hails 'greatest king' Charles as state visit wraps up
-
Drivers help study road-trip mystery: what became of bug splats?
-
Oil strikes 4-year peak, stocks rise
-
Iran's supreme leader defies US blockade as oil prices soar
-
White House against Anthropic expanding Mythos model access: report
-
Oil crisis fuels calls to speed up clean energy transition
Star UK chef redesigns menu for dieters on skinny jabs
When Michelin-starred UK chef Heston Blumenthal turned to skinny jabs to lose weight, his appetite evaporated and he realised the popularity of such medications risked biting into restaurant sales.
So he devised a menu-lite, offering small plates of his star menu -- "The Journey" priced at £350 ($467) per person -- at his Fat Duck restaurant in the village of Bray, west of London.
His website describes the new "Mindful Experience" menu launched in October, costing £275 per person, as "a journey into the culinary creativity and Wonka-like wonderment of Hestonland".
It says the menu is "a scaled-back version of each dish", allowing diners to explore "mindfully, slowly savouring every mouthful, taking the time to detect flavours, textures, aroma".
Following the United States, injections to treat diabetes and weight loss soared in popularity in 2025 in the UK, where they can be bought after consultations at a high-street pharmacy or even prescribed by doctors.
There are no official UK figures for the use of the new generation of such appetite-suppressing drugs called GLP-1 agonists, which include the brands Ozempic, Wegovy and Mounjaro.
But some studies say more than 3.5 million Britons could be using them.
- 'Not hungry' -
"It's only just started. It's just beginning," the 59-year-old Blumenthal told AFP.
He opened The Fat Duck in 1995, which nine years later was crowned with three Michelin stars. His other restaurants in Dubai and London have also won Michelin accolades.
But the celebrity TV chef, known for his playful and innovative creations combining food and science, has openly talked about his struggles since being diagnosed with bipolar disorder two years ago.
The medication he was prescribed led him to gain weight -- some 40 kilograms (88 pounds). His doctor proposed weight-loss drugs.
"When I first started to take it, I was not hungry at all. It was bizarre really. It didn't put me off eating but it was just I was full without being feeling full," Blumenthal said.
He lost 20 kgs in three months but happily the jabs did not kill his tastebuds.
- 'Nitro-poached' -
But the chef "realised that there's a danger for restaurants".
"This is going to have a huge impact on how we eat, on eating out in general."
He saw it as "a big challenge but a thrilling one -- an opportunity to rethink, re-examine, reinvent".
His smaller plates menu starts with a "Nitro-poached aperitif" -- a lime and green tea mousse created with liquid nitrogen which melts in the mouth in seconds.
A signature dish, "Beside the Sea", transports diners to the seaside through taste, sound and smell. While customers dine on edible sand and a crab ice-cream, they listen to seagulls and the sounds of the waves through headphones.
UK government figures show that nearly two-thirds of adults are either overweight or obese, and the National Health Service is staggering under patient demand for the jabs.
Faced with long waiting lists, hundreds of thousands have flocked to UK pharmacies prepared to pay upwards of £175 for a month's worth of jabs, with the costs rising for higher doses.
- 'Concentrating' -
Blumenthal's smaller menu has been a huge success, with only one of the first 80 customers saying they were not full after eating.
The chef -- who these days finds himself spending 10 minutes chewing on a raisin, analysing the taste -- said he does not think he could now tuck into a full plate. "It's too big," he explained.
"When there's less food you can value it more."
"There's something about taking a mouthful and really concentrating on it which changes the way your body is receiving it."
Blumenthal is not the only chef to realise tastes are changing.
Indian chef Atul Kochhar told Britain's Channel 4 TV outlet that he had launched a smaller plates offering.
He "knew there would be an impact on our business" of the skinny jabs, he said, adding "I'd be lying if I was saying I wasn't worried".
"A lot of people were saying, 'It's a bit too much of food, we won't be able to eat it, we don't want to waste it'. So we decided to come with a kind of miniature plate."
Y.Uduike--CPN